| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ffa0aaacc0150ee40ccd2cc347f76ff |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate |
1987-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb1b6ae86cc82e7f49985e2d0fe7947b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9da088b81ecfa682aa948170fe458d9 |
| publicationDate |
1988-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0261891-A2 |
| titleOfInvention |
Pharmaceutical compositions containing etiochiolandione |
| abstract |
Etiocholandione is administered to mammals for the treatment of prophylaxis of diabetes, obesity, hpbercor- ticoidism and bone marrow suppressive disorders. Following administration the dione is converted to al- phaetiocholanolone which is pharmaceutically active. The use of etiocholandione as a pharmaceutical and compositions containing it are described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5824668-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0301546-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9717992-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0301546-A3 |
| priorityDate |
1986-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |